These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16454448)

  • 1. [The influence of body mass reduction on metabolic disorders and complications in patient with morbid obesity. Three years observation].
    Pietrzak-Nowacka M; Safranow K; Kedzierska K
    Pol Arch Med Wewn; 2005 Jun; 113(6):575-9. PubMed ID: 16454448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study.
    Mathus-Vliegen EM;
    Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S31-8; discussion S39. PubMed ID: 16052193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: a randomised controlled clinical trial.
    Astell KJ; Mathai ML; McAinch AJ; Stathis CG; Su XQ
    Complement Ther Med; 2013 Jun; 21(3):180-9. PubMed ID: 23642949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of weight loss on the metabolic syndrome.
    Phelan S; Wadden TA; Berkowitz RI; Sarwer DB; Womble LG; Cato RK; Rothman R
    Int J Obes (Lond); 2007 Sep; 31(9):1442-8. PubMed ID: 17356528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients.
    Early JL; Apovian CM; Aronne LJ; Fernstrom MH; Frank A; Greenway FL; Heber D; Kushner RF; Cwik KM; Walch JK; Hewkin AC; Blakesley V
    Obesity (Silver Spring); 2007 Jun; 15(6):1464-72. PubMed ID: 17557984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine.
    Hainer V; Kunesova M; Bellisle F; Hill M; Braunerova R; Wagenknecht M
    Int J Obes (Lond); 2005 Feb; 29(2):208-16. PubMed ID: 15583700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Principles of nutrition and pharmacotherapy of obesity in patients with obstructive sleep apnea].
    Czech A
    Pneumonol Alergol Pol; 2007; 75 Suppl 1():39-43. PubMed ID: 17440891
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.
    de Simone G; Romano C; De Caprio C; Contaldo F; Salanitri T; di Luzio Paparatti U; Pasanisi F
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):24-30. PubMed ID: 15871847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sibutramine as an adjuvant therapy in adolescents suffering from morbid obesity.
    Reisler G; Tauber T; Afriat R; Bortnik O; Goldman M
    Isr Med Assoc J; 2006 Jan; 8(1):30-2. PubMed ID: 16450748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring synergies in the treatment of obesity.
    Wadden TA
    Postgrad Med; 2001 Jun; 109(6 Suppl):29-33. PubMed ID: 19667565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The "problem obesity": viewpoint of the internist].
    Guagnano MT; Manigrasso MR; Capani F; Davì G
    Ann Ital Chir; 2005; 76(5):407-11. PubMed ID: 16696212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of sibutramine to assist obese women with weight loss can be successful in dietitian-led clinics: another tool in the dietitian's toolbox.
    Barratt R; Frost G; O'Boyle A; Millward J; Truby H
    J Hum Nutr Diet; 2008 Jun; 21(3):248-55. PubMed ID: 18477180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of weight loss on blood pressure].
    Bönner G
    MMW Fortschr Med; 2007 Nov; 149(48):44-7; quiz 48. PubMed ID: 18161437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet-Induced Weight Loss Reduces DNA Damage and Cardiometabolic Risk Factors in Overweight/Obese Women with Polycystic Ovary Syndrome.
    Soares NP; Santos AC; Costa EC; Azevedo GD; Damasceno DC; Fayh AP; Lemos TM
    Ann Nutr Metab; 2016; 68(3):220-7. PubMed ID: 27073909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of meal replacement on metabolic risk factors in overweight and obese subjects.
    König D; Deibert P; Frey I; Landmann U; Berg A
    Ann Nutr Metab; 2008; 52(1):74-8. PubMed ID: 18319587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Obesity and metabolic syndrome: clinical and therapeutic review].
    Cuppini A; Matteini P
    Monaldi Arch Chest Dis; 2005 Mar; 64(1):45-9. PubMed ID: 16128165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin versus sibutramine in the treatment of hyperinsulinemia in chronically anovulating women.
    Lazurova I; Dravecka I; Kraus V; Petrovicova J
    Bratisl Lek Listy; 2004; 105(5-6):207-10. PubMed ID: 15535111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.